GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural help

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Nabi, Ghulam ^a   Genannt Bonsmann, Michael S ^a   Tenbusch, Matthias ^a   Gardt, Oliver ^a   Barouch, Dan H ^b,c   Temchura, Vladimir ^a   Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Env antibody response; Gag specific CD4+ T cells; HIV VLPs; Intrastructural help; SIV

Indexed keywords

ADENOVIRUS VECTOR; DNA VACCINE; GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION;

MACACA MULATTA; MUS; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; IMMUNIZATION; MICE; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, DNA; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84885962913     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-117     Document Type: Article

References (15)

1. Casimiro DR, Wang FB, Schleif WA, Liang XP, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J Virol 2005, 79:15547-15555. 10.1128/JVI.79.24.15547-15555.2005, 1315991, 16306625.
2. Liu JY, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009, 457:87-91. 10.1038/nature07469, 2614452, 18997770.
3. Liang XP, Casimiro DR, Schleif WA, Wang FB, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, et al. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6p challenge in Mamu-A*01-negative rhesus monkeys. J Virol 2005, 79:12321-12331. 10.1128/JVI.79.19.12321-12331.2005, 1211517, 16160159.
4. Milich DR, Mclachlan A, Thornton GB, Hughes JL. Antibody-production to the nucleocapsid and envelope of the hepatitis-B virus primed by a single synthetic T-cell site. Nature 1987, 329:547-549. 10.1038/329547a0, 2443856.
5. Scherle PA, Gerhard W. Functional-analysis of influenza-specific helper T-cell clones invivo - T-cells specific for internal viral-proteins provide cognate help for B-cell responses to hemagglutinin. J Exp Med 1986, 164:1114-1128. 10.1084/jem.164.4.1114, 2188433, 2944982.
6. Scherle PA, Gerhard W. Differential ability of B-cells specific for external Vs internal influenza-virus proteins to respond to help from influenza virus-specific T-cell clones invivo. Proc Natl Acad Sci USA 1988, 85:4446-4450. 10.1073/pnas.85.12.4446, 280446, 3260034.
7. Russell SM, Liew FY. T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature 1979, 280:147-148. 10.1038/280147a0, 317881.
8. Russell SM, Liew FY. Cell cooperation in antibody-responses to influenza-virus.1. Priming of helper T-cells by internal components of the virion. Euro J Immunol 1980, 10:791-796.
9. Forthal DN, Landucci G, Daar ES. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells. J Virol 2001, 75:6953-6961. 10.1128/JVI.75.15.6953-6961.2001, 114423, 11435575.
10. Gardt O, Grewe B, Tippler BG, Überla K, Temchura VV. HIV-derived lentiviral particles promote T-cell independent activation and differentiation of naïve cognate conventional B2-cells in vitro. Vaccine 2013, 31:5088-5098. 10.1016/j.vaccine.2013.08.055, 24029115.
11. Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, Johnston RJ, Peters L, Benhnia MREI, Hoffmann J, Su HP, et al. Selective CD4(+) T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 2008, 28:847-858. 10.1016/j.immuni.2008.04.018, 2504733, 18549802.
12. Wagner R, Graf M, Bieler K, Wolf H, Grunwald T, Foley P, Überla K. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther 2000, 11:2403-2413. 10.1089/104303400750038507, 11096444.
13. Kuate S, Stefanou D, Hoffmann D, Wildner O, Überla K. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses. J Gene Med 2004, 6:1197-1205. 10.1002/jgm.623, 15459964.
14. Stahl-Hennig C, Kuate S, Franz M, Suh YS, Stoiber H, Sauermann U, Tenner-Racz K, Norley S, Park KS, Sung YC, et al. Atraumatic oral spray immunization with replication-deficient viral vector vaccines. J Virol 2007, 81:13180-13190. 10.1128/JVI.01400-07, 2169087, 17898066.
15. Aricescu AR, Lu WX, Jones EY. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystall Sect D-Biol Crystall 2006, 62:1243-1250.